Invention Grant
- Patent Title: Methods of monitoring conditions by sequence analysis
-
Application No.: US15820655Application Date: 2017-11-22
-
Publication No.: US10246752B2Publication Date: 2019-04-02
- Inventor: Malek Faham , Thomas Willis
- Applicant: Adaptive Biotechnologies Corp.
- Applicant Address: US WA Seattle
- Assignee: Adaptive Biotechnologies Corp.
- Current Assignee: Adaptive Biotechnologies Corp.
- Current Assignee Address: US WA Seattle
- Agency: Cooley LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6886 ; C12Q1/6827 ; C12N15/10 ; C12Q1/6881 ; C12Q1/6883 ; C12Q1/6869
Abstract:
There is a need for improved methods for determining the diagnosis and prognosis of patients with conditions, including autoimmune disease and cancer. Provided herein are methods for using DNA sequencing to identify personalized biomarkers in patients with autoimmune disease and other conditions. Identified biomarkers can be used to determine the disease state for a subject with an autoimmune disease or other condition.
Public/Granted literature
- US20180112278A1 METHODS OF MONITORING CONDITIONS BY SEQUENCE ANALYSIS Public/Granted day:2018-04-26
Information query
